UCL denames buildings named after eugenicists
By University College London,
UCL News
| 06. 19. 2020
The decision was made by UCL’s President & Provost Professor Michael Arthur and ratified by Council - the university’s governing body - following a recommendation from UCL’s Buildings Naming and Renaming Committee.
Signs on the Galton Lecture Theatre, Pearson Building and Pearson Lecture Theatre will be taken down with immediate effect. Other changes to the names on maps and signposts around the UCL estate will take place as soon as is practicable.
Victorian scientist Francis Galton coined the term eugenics and endowed UCL with his personal collection and archive along with a bequest for the country’s first professorial Chair of Eugenics. Karl Pearson was the first holder of this chair.
The move is one step in a range of actions aimed at acknowledging and addressing the university’s historical links with the eugenics movement. It follows a series of recommendations made by members of the Inquiry into the History of Eugenics at UCL, which reported earlier this year.
A Response Group of senior UCL representatives – including academic staff, equality experts and the Students’ Union – is being formed to consider...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Angus Liu, Fierce Pharma | 06.16.2025
A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy (DMD) gene therapy’s safety profile.
Sarepta and its ex-U.S. partner Roche reported the death early Sunday. Like the first case, disclosed...
By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025
A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.
Bootstrap Bio...
